Role of renal nerves in development of hypertension in DOCA-salt model in rats: A telemetric approach

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 289, Issue 4 58-4, 2005, Pages

  Jacob, Frédéric ^a,c   Clark, Leah A ^a   Guzman, Pilar Ariza ^a   Osborn, John W ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Deoxycorticosterone salt hypertension; Renal denervation; Sympathetic renal nerves

Indexed keywords

DEOXYCORTICOSTERONE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE MODEL; FLUID BALANCE; HEART RATE; HYPERTENSION; KIDNEY DENERVATION; KIDNEY NERVE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PERIPHERAL VASCULAR SYSTEM; PRIORITY JOURNAL; RAT; RAT STRAIN; RISK FACTOR; SALT INTAKE; SODIUM BALANCE; SYMPATHETIC TONE; TELEMETRY;

ANIMALS; BLOOD PRESSURE; BODY WEIGHT; DESOXYCORTICOSTERONE; DISEASE MODELS, ANIMAL; HEART RATE; HYPERTENSION, RENAL; KIDNEY; MALE; RATS; RATS, SPRAGUE-DAWLEY; RENAL CIRCULATION; SODIUM CHLORIDE; SYMPATHECTOMY; SYMPATHETIC NERVOUS SYSTEM; TELEMETRY; WATER-ELECTROLYTE BALANCE;

EID: 25444500668     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00206.2005     Document Type: Article

References (47)

1. Berecek KH and Bohr DF. Whole body vascular reactivity during the development of deoxycorticosterone acetate hypertension in the pig. Circ Res 42: 764-771, 1978.
2. Berecek KH, Murray RD, and Gross F. Significance of sodium, sympathetic innervation, and central adrenergic structures on renal vasculature responsiveness in DOCA-treated rats. Circ Res 47: 675-683, 1980.
3. Berreta-Piccoli C, Davies DL, and Brown JJ. Relation of blood pressure with body and plasma electrolytes in Conn's syndrome. J Hypertens 1: 197-205, 1983.
4. Biaggioni I. Sympathetic control of the circulation in hypertension: lessons from autonomic disorders. Curr Opin Nephrol Hypertens 12: 175-180, 2003.
5. Bohr DF. What makes the pressure go up? Hypertension 3, Suppl 2: II160-II165, 1981.
6. Bohr DF and Dominiczak AF. Experimental hypertension. Hypertension 17, Suppl 1: I39-IS44, 1991.
7. Brody MJ. Central nervous system and mechanisms of hypertension. Clin Physiol Biochem 6: 230-239, 1988.
8. Brody MJ, Varner KJ, Vasquez EC, and Lewis SJ. Central nervous system and the pathogenesis of hypertension. Hypertension 18, Suppl 5: III7-III12, 1991.
9. Calaresu FR and Ciriello J. Renal afferent nerves affect discharge rate of medullary and hypothalamic single units in the cat. J Auton Nerv Syst 3: 311-320, 1981.
10. Campese VM and Kogosov E. Renal afferent denervation prevents hypertension in rats with chronic renal failure. Hypertension 25: 878-882, 1995.
11. Clarke DE, Smookler HH, and Barry H. Sympathetic nerve function and DOCA-NaCl induced hypertension. Life Sci 9: 1097-1108, 1970.
12. DiBona GF and Kopp UC. Neural control of renal function. Physiol Rev 77: 77-197, 1997.
13. Dzielak DJ and Norman JR. Renal nerves are not necessary for onset or maintenance of DOC-salt hypertension in rats. Am J Physiol Heart Circ Physiol 249: H945-H949, 1985.
14. Finch L and Leach GDH. The contribution of the sympathetic nervous system to the development and maintenance of experimental hypertension in the rat. Br J Pharmacol 39: 317-324, 1970.
15. Fink GD, Johnson RJ, and Galligan JJ. Mechanisms of increased venous smooth muscle tone in deoxycorticosterone acetate-salt hypertension. Hypertension 35: 464-469, 2000.
16. Fink GD, Pawloski CM, Blair ML, and Mangiapane ML. The area postrema in deoxycorticosterone-salt hypertension in rats. Hypertension 6: III206-III209, 1987.
17. Garty H. Regulation of epithelial sodium channel by aldosterone: open questions and emerging answers. Kidney Int 57: 1270-1276, 2000.
18. Gomez-Sanchez EP. Brain mineralocorticoid receptors: orchestrator of hypertension and end-organ disease. Curr Opin Nephrol Hypertens 13: 191-196, 2004.
19. Gomez-Sanchez EP. What is the role of the central nervous system in mineralocorticoid hypertension? Am J Hypertens 4: 374-381, 1991.
20. Gomez-Sanchez EP, Fort CM, and Gomez-Sanchez CE. Intracerebroventricular infusion of RU28318 blocks aldosterone-salt hypertension. Am J Physiol Endocrinol Metab 258: E482-E484, 1990.
21. Guyton AC. Dominant role of the kidneys and accessory role of whole-body autoregulation in the pathogenesis of hypertension. Am J Hypertens 2: 575-585, 1989.
22. Guyton AC, Coleman TG, Cowley AW, Scheel KW, Manning RD, and Norman RA. Arterial pressure regulation: overriding dominance of the kidneys in long-term control and in hypertension. Am J Med 52: 584-594, 1972.
23. Huang M, Hester RL, Coleman TG, Smith MJ, and Guyton AC. Development of hypertension in animals with reduced total peripheral resistance. Hypertension 20: 828-833, 1992.
24. Jacob F, Ariza P, and Osborn JW. Renal denervation chronically lowers arterial pressure independent of dietary sodium intake in normal rats. Am J Physiol Heart Circ Physiol 284: H2302-H2310, 2003.
25. Jacob F, LaBine BG, Ariza P, Katz SA, and Osborn JW. Renal denervation causes chronic hypotension in rats: role of beta1-adrenoceptor activity. Clin Exp Pharmacol Physiol 32: 255-262, 2005.
26. Janssen BJA, Essen HV, Vervoot-Peters LHTM, Struyker-Boudier HAJ, and Smits JFM. Role of afferent renal nerves in spontaneous hypertension in rats. Hypertension 13: 327-333, 1989.
27. Katholi RE, Naftilan AJ, Bishop SP, and Oparil S. Role of renal nerves in the maintenance of DOCA-salt hypertension in the rat. Influence on the renal vasculature and sodium excretion Hypertension 5: 427-435, 1983.
28. Katholi RE, Naftilan AJ, and Oparil S. Importance of renal sympathetic tone in the development of DOCA-salt hypertension in the rat. Hypertension 2: 266-273, 1980.
29. Katholi RE, Whitlow PL, Hageman GR, and Woods WT. Intrarenal adenosine produces hypertension by activating the sympathetic nervous system via the renal nerves in the dog. J Hypertens 2: 349-359, 1984.
30. Kopp UC, Cicha MZ, and Smith LA. Dietary sodium loading increases arterial pressure in afferent renal-denervated rats. Hypertension 42: 968-973, 2003.
31. Onoyama K, Bravo EL, and Tarazi RC. Sodium, extracellular fluid volume, and cardiac output changes in the genesis of mineralocorticoid hypertension in the intact dog. Hypertension 1: 331-336, 1979.
32. Oparil S, Sripairojthikoon W, and Wyss JM. The renal afferent nerves in the pathogenesis of hypertension. Can J Physiol Pharmacol 65: 1548-1558, 1987.
33. Passmore JC, Jimenez AE, and Pierce WM. Cardiac output and the blood pressure increase in deoxycorticosterone acetate-salt hypertension after nicotine infusion. Clin Exp Hypertens A13: 83-102, 1991.
34. Sakai RR, McEwen BS, Fluharty SJ, and Ma LY. The amygdala:site of genomic and nongenomic arousal of aldosterone-induced sodium intake. Kidney Int 57: 1337-1345, 2000.
35. Shimamoto H and Iriuchijima J. Hemodynamic characteristics of conscious deoxycorticosterone acetate hypertensive rats. Jpn J Physiol 37: 243-254, 1987.
36. Simon JK and Ciriello J. Contribution of afferent renal nerves to the metabolic activity of central structures involved in the control of the circulation. Can J Physiol Pharmacol 67: 1130-1139, 1989.
37. Stella A and Zanchetti A. Interactions between the sympathetic nervous system and the kidney: experimental observations. J Hypertens 3, Suppl 4: S19-S25, 1985.
38. Takahashi H, Iyoda I, Yamasaki H, Takeda K, Okajima H, Sasaki S, Yoshimura M, Nakagawa M, and Ijichi H. Retardation of the development of hypertension in DOCA-salt rats by renal denervation. Jpn Circ J 48: 567-574, 1984.
39. Thunhorst BJL, Kirby RF, and Johnson AK. Role of renal nerves in sodium depletion-induced salt appetite. Am J Physiol Regul Integr Comp Physiol 271: R806-R812, 1996.
40. Trostel KA and Osborn JW. Do renal nerves chronically influence renal function and arterial pressure in spinal rats? Am J Physiol Regul Integr Comp Physiol 263: R1265-R1270, 1992.
41. Ueda H, Uchida Y, and Kamisaka K. Mechanism of the reflex depressor effect by kidney in dog. Jpn Heart J 8: 597-606, 1967.
42. Ueno Y, Mohara O, Brosnihan B, and Ferrario CM. Characteristics of hormonal and neurogenic mechanisms of deoxycorticosterone-induced hypertension. Hypertension 2, Suppl I: S172-S177, 1988.
43. Webb RC. Increased vascular sensitivity to serotonine and methysergide in hypertension. Clin Sci (Lond) 63: 735-755, 1982.
44. Wyss JM, Abourkarsh N, and Oparil S. Sensory denervation of the kidney attenuated renovascular hypertension in the rat. Am J Physiol Heart Circ Physiol 250: H80-H86, 1986.
45. Ye S, Ozgur B, and Campese VM. Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure. Kidney Int 51: 722-727, 1997.
46. Zambraski EJ, Ciccone CD, and Izzo JL. The role of sympathetic nervous system in 2-kidney DOCA-hypertensive Yucatan miniature swine. Clin Exp Hypertens A8: 411-424, 1986.
47. Zicha J and Kunes J. Hemodynamic changes induced by short- and long-term sodium chloride or sodium bicarbonate intake in deoxycorticosterone-treated rats. Acta Physiol Scand 151: 217-223, 1994.